| abstract |
The present invention refers to compounds of formula I comprising a prenylated benzopyran central structure.Said compounds of formula I, stereoisomers and pharmaceutically acceptable salts show activity as agonists of PPARα, PPARγ, or dual activity as agonists of PPARα and PPARγ. Therefore, compounds having said prenylated benzopyran structure of formula I, the pharmaceutically acceptable salts thereof are described, as well as the first medical use thereof, and the use of compounds having a prenylated benzopyran structure in the treatment of diseases responding to the administration of PPARα and/or PPARγ agonists. |